Web Analytics
INCR (NASDAQ) Stock Analysis | INTERCURE LTD. – Deepscope
MARKET

Select Market Data Region

INCR Stock Analysis — INTERCURE LTD. (Healthcare >> Drug Manufacturers - Specialty & Generic)

INCR FAQ

What is INCR's ROE?

INTERCURE LTD. reports a Return on Equity (ROE) of -9.01%.

What is INCR's dividend yield?

INTERCURE LTD. offers a dividend yield of 0.00%.

What is INCR's Quality Score?

Our AI rates INCR's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy INCR?

Our AI Timing Score for INCR is 2 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does INCR belong to?

INTERCURE LTD. is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange

Stock Check   *Daily update data at 8:30 AM*
(Price: 2026-07-31 | FS: 2026-03-31)

INCR AI Analysis Summary

Our AI summary for INCR: INTERCURE LTD. (NASDAQ), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 0.00, ROE of -9.01%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 2/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

USD 0.96
0.01 (1.41%) Day Change
0.26
D/E
-9.0%
ROE
-5.2%
ROA
0.00%
Div Yield
USD 0.96
Price
0.01 (1.41%)
Day Change
NEWS SCORE: 97

INCR, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...

38

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Momentum indicators aligned on the daily timeframe
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors 42%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 97
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 0.96
  PBV / Sector
0.14 / 3.22
GREAT
  Earning Per Share -0.61
  PE / Sector
N/A / 29.79
  PEG or PE/Growth / Sector
N/A / 0.13
  Average 1M Daily Value
0.02 M
GREAT
  Average 1W Daily Value
0.02 M
GREAT
Timing Factors 57%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 45%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Ability to Make Profit 45%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-13.22 / 15.21
  NPM Average (%) / Sector
-12.14 / -10.83
  NPM Change Average (%) / Sector
-60.42 / 117.42
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-5.17 / 8.15
  ROA Average (%) / Sector
-4.49 / 2.87
  ROA Change Average (%) / Sector
-74.33 / 112.70
  ROE (%) / Sector
-9.01 / -1.02
  ROE Average (%) / Sector
-7.95 / 8.35
  ROE Change Average (%) / Sector
-68.52 / 385.91
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Return to Investors 4%
X
  Dividend (%) / Sector
N/A / 0.51
  Dividend Average (%) / Sector
N/A / 3.06
  Dividend Change Average (%) / Sector
N/A / 13.64
Registration Details
X
  Analyze Date 2026-08-01 08:00:01
  Symbol INCR
  Name INTERCURE LTD.
  Sector Healthcare >> Drug Manufacturers - Specialty & Generic
  Market NASDAQ
  Listed Shares 59.23 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 56.17 / 10,754.62
News, Concensus, ...
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670

Phone: 972 7 746 05012

Website: https://www.intercure.co

Employees: 285

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic

INCR (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

Stocks in the Same Sector

Healthcare › Drug Manufacturers - Specialty & Generic

Analysed on the same criteria, ordered by market cap

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
INCR
INCR
USD 0.96 (1.41%)
+ Watch + Port Chart